It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Cutaneous T-Cell Lymphoma Treatment Study

Clinical Trial Title: 
A phase 3 multicenter, randomized, placebo-controlled study to determine the effect of topical SGX301 and fluorescent bulb-light irradiation for the treatment of cutaneous T-cell lymphoma.
Clinical Trial Protocol ID: 
15041601
Clinical Trial Investigator Name: 
Michael D. Tharp, MD
Clinical Trial Protocol Description: 

Rush Dermatology seeks volunteers with a diagnosis of cutaneous T-cell lymphoma (CTCL) or mycosis fungoides (MF) for a clinical trial testing an investigational medication. All office visits and treatments are provided free of charge.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are 18 years or older.
  • Have a diagnosis of CTCL or MF (Stage 1A, 1B, or 2A).
  • Have at least 3 lesions.
  • Are willing to come to Rush 2 to 4 days per week.

This is a partial list of elgibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Blood Disorders and Hematologic Cancers
Dermatology
Contact Email: 
Contact Phone: 
(312) 563-4001
Contact Name: 
Carmen Petrizzo or Danica Uzelac